Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)

NCT02973477 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes
Cardiovascular Diseases

Interventions

DRUG: Dapagliflozin
DRUG: Glimepiride

Sponsor

University of Michigan

Collaborators

[object Object]